DDIP USA / East Coast
Drug Discovery
Innovation Programme
Where Drug Discovery Experts Connect, Collaborate & Innovate
The Drug Discovery Community,
All in One Place
0+
Drug Discovery Leaders
0+
Industry Speakers
0%
Pharma & Biotech
0+
Networking Hours
0+
1:1 Meetings
About DDIP 2027
DDIP 2027 brings together scientists, innovators and industry leaders working at the forefront of drug discovery to explore what is changing, what is emerging and what comes next. From discovery to next-generation therapies, DDIP 2027 offers a focused platform for sharing scientific insights and real-world experiences.
Exchange Real-World Insights
Build Meaningful Connections
Explore. Exchange. Innovate.
Featured Speakers
Hear from leading minds shaping the future of drug discovery.
Igor Nasonkin
Founder, CEO & Chief Scientific Officer
Phythera Therapeutics, Inc
Thomas Nittoli
Senior Director
Regeneron Pharmaceuticals
Istvan Enyedy
Senior Director Computational Chemistry
Third Harmonic Bio
Leo Kirkovsky
Sr. Director
Exelixis
Michael N. Liebman
Managing Director, Co-Founder
IPQ Analytics, LLC
Rick Ewing
VP, Head of Chemistry
Rapafusyn Research and Development
Hariprasad Vankayalapati, M. Pharm., PhD
Chief Scientific Officer
Biolexis Therapeutics, Inc.
David Bearss Ph.D
Co-Founder, CEO, President and Chairman Of The Board
Halia Therapeutics
Who Will You Meet?
Pharma & Biotech Founders, CEOs and Scientists of
Target Identification & Validation
Biologics and Advanced Therapeutics
Hit Discovery & Screening
Medicinal Chemistry & SAR
Computational Drug Discovery / AI & ML
Molecular Docking & Virtual Screening
ADME/DMPK & Toxicology
Biomarkers & Translational Research
Preclinical Drug Development & Drug Design
Biologics & Therapeutic Antibodies
Join the room
Get Attendee List
Meet founders, CEOs and scientists shaping the future of drug discovery.
What Industry Leaders Say
Voices from past delegates across pharma, biotech and discovery science.
Current Trends in the Pharmaceutical Industry are well covered, including emerging technologies, and evolving market dynamics.
An outstanding conference that brought together diverse pharma experts and delivered valuable insights into drug discovery and product development.
Inspiring and well-organized conference. The agenda has offered a good balance of panel moderation and networking.
A nice balance of scientific insights and business development perspectives, providing a well-rounded understanding of the pharmaceutical industry.
Diversity of different types of talks, variety of discussion which you had and interaction of people all across the drug development cycle.
I would definitely recommend this event, it brings many elements useful to look at how AI is really transforming drug discovery.
Choose Your Pass
Full Event Access
All Sessions
Industry Networking
Venue
A Leading Hub for Drug Discovery & Life Sciences
New Jersey and the wider Princeton region bring together a world-class ecosystem of pharmaceutical, biotechnology, academic, and life-sciences organizations, making it an ideal setting for the Drug Discovery Innovation Programme USA 2027.
Connect with leading scientists, R&D executives, pharmaceutical and biotech innovators, researchers, technology providers, and investors while exploring breakthrough approaches, emerging technologies, and collaborative opportunities shaping the future of drug discovery and therapeutic development.
The DDIP Experience
Where Conversations Become Connections
Platforms & tools
Innovation Showcase
Experience technologies and platforms transforming modern drug discovery.
Meetings to Deals
Collaboration Exchange
Connect with industry leaders, explore commercial opportunities, and build strategic relationships.
Capital & science
Business Matchmaking
Strong partnerships with the right businesses pave the way for meaningful, long-term growth.
Latest Talks
Scientific Discussions
Move beyond presentations into focused conversations around specific discovery challenges and opportunities.
1:1 meetings
Industry Networking
Meet more of the community through structured, high-value conversations.
Contact
The Right Person. The Right Conversation.
Speak directly with the team handling speaking, tickets, sponsorship and media.
Ashley King
Speaker Acquisitions Executive
speaking@worldbigroup.comHannah Jones
Delegate Manager
events@worldbigroup.comMatthew Rose
Sponsorship Manager
sponsorship@worldbigroup.comTina Aston
Media Partnerships Executive
media@worldbigroup.comMessage sent
Thank you. The right person on our team will follow up shortly.
Moments from Our
Past DDIP Editions.
Frequently Asked Questions
Everything you need before registering for DDIP USA 2027.
Still Deciding?
Register your interestDDIP USA 2027 is a one-day drug discovery conference bringing together scientists, innovators, and industry leaders across target identification, computational drug design, medicinal chemistry, and next-generation therapeutics. It takes place on 17 June 2027 in Princeton, New Jersey.
DDIP USA is built for professionals across the drug discovery pipeline — from target identification & hit discovery to computational drug discovery (AI/ML), medicinal chemistry, ADME/DMPK, biologics, and clinical development. Founders, CEOs, and senior scientists from pharma and biotech companies make up the core audience, with 80% of attendees coming from pharma & biotech.
Instead of generic networking, DDIP USA is built around structured, high-value formats — a Startup Pitch Arena for emerging biotech ventures, Investor Matchmaking, an Innovation Showcase, and focused roundtable discussions — so every attendee leaves with concrete connections, not just notes from a keynote.
DDIP USA brings together 70+ drug discovery leaders and 15+ industry speakers, with 6+ hours of structured networking and 30+ curated 1:1 meetings designed to turn conversations into real collaborations.
You can register as a delegate, apply to pitch in the Startup Pitch Arena, or explore sponsorship and speaking opportunities. Register your interest or view pricing & partnership options.